NCT00597649View on ClinicalTrials.gov

A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

PHASE2TerminatedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Chronic Peripheral Neuropathy Pain in Diabetics
Interventions
DRUG

Bicifadine

SR dosage form of 400 mg bid or tid for one year

Trial Locations (1)

Unknown

Four Rivers Clinical Research, Paducah

Sponsors
All Listed Sponsors
lead

XTL Biopharmaceuticals

INDUSTRY